Is Target Stock a Hidden Gem for Patient Value Investors?
Target (NYSE: TGT) hasn’t had the best run lately. In fact, shares have slid 29.9% so far this year, a sharp contrast to the broader market, with the S&P 500 flat on the year. It’s a tough pill to swallow, especially when you consider Target was already on the back foot coming into 2025.
But here’s the twist,
» Read more about: Is Target Stock a Hidden Gem for Patient Value Investors? »
Read More
1 Top Healthcare Firm Set To Pop
UnitedHealth Group, with a market capitalization of around $454 billion, is the largest health insurer in the United States, serving nearly 50 million Americans.
It benefits from unparalleled market presence and scale that grants it significant bargaining power, which in turn ensures lower costs and higher margins compared to its competitors.
Over the past decade,
» Read more about: 1 Top Healthcare Firm Set To Pop »
Read More
Is Apple’s Dip The Perfect Buying Opportunity?
Apple has fallen by almost 15% from nearly $200 per share in recent months. The decline appeared to precede the major market averages more recent correction but does it bode ominously for Apple or has the recent pullback offered new buyers an opportunity to get in on a great company at sale prices?
In the near-term,
» Read more about: Is Apple’s Dip The Perfect Buying Opportunity? »
Read More
Will This $20 Million Bet Pay Off?
A report just came out that one trader bet a massive $20 million on a single stock rising by 30% on its next earnings report. That stock is, drumroll, artificial intelligence favorite, Nvidia.
The bet was made by purchasing strike 1180 call options on Nvidia for the June expiration, meaning if NVDA share price rise were to rise above that level on expiration day,
» Read more about: Will This $20 Million Bet Pay Off? »
Read More
Will This AI Goliath Hit $4 Trillion by 2027?
While no company has reached that towering $4 trillion milestone yet, Microsoft, Apple, and Nvidia are all within striking distance.
It’s not inconceivable that any one of them could be first past the post but if you’re asking who not only gets there, but stays there, the strongest case can be made for Microsoft.
» Read more about: Will This AI Goliath Hit $4 Trillion by 2027? »
Read MoreThe Burst
Is Lululemon Losing Its Shine, or Just Catching Its Breath?
When an apparel brand starts showing signs of stress, sales sliding, margins crumbling, losses mounting, the Street doesn’t hesitate to slap the “dying business” label on it.
That’s why it might surprise some investors that Lululemon doesn’t actually fit that description right now. In Q2, sales rose, margins held within historical ranges, and earnings only marginally dipped.
» Read more about: Is Lululemon Losing Its Shine, or Just Catching Its Breath? »
Read MoreThe Ivy
Ken Griffin’s Big Trim in Palantir
In the second quarter of 2025, Ken Griffin’s Citadel Advisors sharply reduced its holding in Palantir Technologies, selling nearly half of its position.
The move raised about $75 million in cash and followed a familiar pattern for Griffin, who has been building and trimming his Palantir stake in waves since 2021.
This latest sale has investors wondering: why would one of Wall Street’s most sophisticated fund managers cut exposure to a stock riding the artificial intelligence boom?
» Read more about: Ken Griffin’s Big Trim in Palantir »
Read MoreThe Daily
3 ETFs That Are Better Than the S&P 500 for Long-Term Returns
© CL STOCK / Shutterstock.com
The S&P 500 is the most well-known benchmark, and buying an ETF focused on this index could have yielded good long-term returns. However, investors can boost their returns by testing the waters and putting their money into ETFs that show more promise.
» Read more about: 3 ETFs That Are Better Than the S&P 500 for Long-Term Returns »